Although studies have reported previously that patients with B-cell follicular lymphoma show a loss of expression of the CD20 antigen on tumor cells[8-11], the incidence of this loss and its potential impact on patient’s outcome remains unknown. Here, MS4A1 is linked to neoplasm.